Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.2M Sell
5,305,746
-464,325
-8% -$3.08M ﹤0.01% 2194
2026
Q1
$29.9M Sell
5,770,071
-205,274
-3% -$1.28M ﹤0.01% 2180
2025
Q4
$43.7M Buy
5,975,345
+4,293,966
+255% +$41.6M 0.01% 1750
2025
Q3
$16.8M Sell
1,681,379
-651,349
-28% -$7.21M ﹤0.01% 2757
2025
Q2
$21.1M Buy
2,332,728
+475,659
+26% +$3.1M ﹤0.01% 2305
2025
Q1
$11.9M Buy
1,857,069
+729,687
+65% +$6.49M ﹤0.01% 2856
2024
Q4
$10.7M Buy
1,127,382
+580,910
+106% +$5.1M ﹤0.01% 2960
2024
Q3
$4.47M Buy
546,472
+68,320
+14% +$710K ﹤0.01% 3192
2024
Q2
$6.47M Sell
478,152
-133,205
-22% -$1.11M ﹤0.01% 2605
2024
Q1
$4.28M Sell
611,357
-59,196
-9% -$514K ﹤0.01% 3133
2023
Q4
$7.35M Buy
670,553
+161,624
+32% +$1.59M ﹤0.01% 2367
2023
Q3
$5.59M Buy
508,929
+39,059
+8% +$558K ﹤0.01% 2466
2023
Q2
$7.42M Buy
469,870
+74,158
+19% +$863K ﹤0.01% 2213
2023
Q1
$5.16M Buy
395,712
+120,789
+44% +$992K ﹤0.01% 2487
2022
Q4
$2.99M Sell
274,923
-137,293
-33% -$1.69M ﹤0.01% 2977
2022
Q3
$6.61M Buy
412,216
+255,319
+163% +$3.77M ﹤0.01% 2111
2022
Q2
$1.22M Sell
156,897
-1,688
-1% -$15.9K ﹤0.01% 3569
2022
Q1
$1.98M Buy
158,585
+67,714
+75% +$950K ﹤0.01% 3435
2021
Q4
$2.17M Buy
90,871
+90,768
+88,124% +$2.2M ﹤0.01% 3658
2021
Q3
$2K Buy
+103
New +$1.55K ﹤0.01% 8943
2021
Q2
Sell
-2,291
Closed -$27K 9474
2021
Q1
$27K Buy
+2,291
New +$30.1K ﹤0.01% 7091

Other funds holding ENVX

UBS Group's ENVX Position: Q2 2026 in Review

UBS Group reduced its Enovix (ENVX) stake by 8% in Q2 2026, selling an estimated $3.08M and leaving 5,305,746 shares worth $32.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

UBS Group first reported a position in ENVX in Q1 2021 and has held it in 21 quarters since. The position peaked at $43.7M in Q4 2025. 299 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • UBS Group held 5,305,746 shares of Enovix worth $32.2M as of Q2 2026.
  • UBS Group sold 464,325 Enovix shares in Q2 2026, an estimated $3.08M.
  • Enovix made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2194 holding.
  • UBS Group first reported a position in Enovix in Q1 2021 and has held it in 21 quarters since.
  • UBS Group's Enovix position peaked at $43.7M in Q4 2025.
  • 299 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.